Carlos Martinez-Murillo
Overview
Explore the profile of Carlos Martinez-Murillo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Castro-Leyva V, Manuel-Apolinar L, Basurto-Acevedo N, Basurto L, Gonzalez-Chavez A, Ruiz-Gastelum E, et al.
Arch Med Res
. 2024 Jul;
55(5):103032.
PMID: 38971127
Background: Adiposity favors several metabolic disorders with an exacerbated chronic pro-inflammatory status and tissue damage, with high levels of plasminogen activator inhibitor type 1 (PAI-1) and proprotein convertase subtilisin/kexin type...
2.
Basurto L, Manuel-Apolinar L, Robledo A, OLeary S, Martinez-Murillo C, Medina-Ortiz L, et al.
Clin Investig Arterioscler
. 2024 Jan;
36(4):201-209.
PMID: 38216379
Objective: To assess thrombotic risk with PAI-1 levels in patients with COVID-19, to evaluate PAI-1 differences between hyperglycemic and/or Type 2 Diabetes Mellitus (T2DM) versus non-hyperglycemic patients, and to analyze...
3.
Ramos-Penafiel C, Perez-Samano D, Olarte-Carrillo I, Gallardo-Rodriguez A, Cordero-Hernandez E, Martinez-Murillo C, et al.
Salud Publica Mex
. 2023 Dec;
65(4, jul-ago):316-317.
PMID: 38060896
No abstract available.
4.
Ceron R, Martinez A, Ramos C, De la Cruz A, Garcia A, Mendoza I, et al.
Onco Targets Ther
. 2023 Jan;
15:1583-1595.
PMID: 36606244
Purpose: Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous malignant lymphoid neoplasm and is the most common subtype of non-Hodgkin lymphoma in adults. More than half of patients with DLBCL...
5.
Gallardo-Rodriguez A, Martinez-Murillo C, Perez-Samano D, Olarte-Carrillo I, Martinez-Tovar A, Ramos-Penafiel C
Salud Publica Mex
. 2022 Sep;
64(5, sept-oct):445-446.
PMID: 36130354
No disponible.
6.
Balcazar-Hernandez L, Basurto L, Manuel-Apolinar L, Vega-Garcia S, Basurto-Acevedo N, Martinez-Murillo C, et al.
Metabolites
. 2021 Nov;
11(11).
PMID: 34822430
Variations in levels of some adipokines, myokines, osteokines, hepatokines and inflammatory cytokines contribute to abnormal glucose and lipid metabolism. The aim of this study was to determine the pattern of...
7.
Martinez-Murillo C, Ramos Penafiel C, Basurto L, Balcazar-Hernandez L, Pellon K, Flores Lopez E, et al.
Endocrinol Diabetes Metab
. 2021 Jul;
4(3):e00279.
PMID: 34277995
Aims: To evaluate the frequency of diabetes and admission hyperglycaemia in Mexican COVID-19 patients, to describe the clinical and biochemical characteristics of patients with admission hyperglycaemia and to determinate the...
8.
Ramos-Penafiel C, Santos-Gonzalez B, Flores-Lopez E, Galvan-Flores F, Hernandez-Vazquez L, Santoyo-Sanchez A, et al.
Gac Med Mex
. 2020 Dec;
156(5):405-411.
PMID: 33372941
Introduction: Various biomarkers based on blood counts have been useful for the prognosis of patients critically ill with COVID-19. Objective: To describe the usefulness of the neutrophil-to-lymphocyte (NLR), monocyte-to-lymphocyte (MLR)...
9.
Basurto L, Sanchez L, Diaz A, Valle M, Robledo A, Martinez-Murillo C
Thromb Res
. 2019 Jul;
180:110-114.
PMID: 31288156
Background: Different studies have recognized the existence of subtypes of obesity and normal weight, in which it is reported that not all patients show the same cardiometabolic risk, called "metabolically...
10.
Basurto L, Diaz A, Rodriguez A, Robledo A, Vega S, Garcia-Vega J, et al.
Gynecol Endocrinol
. 2019 Apr;
35(10):909-912.
PMID: 31023101
The plasminogen activator inhibitor type 1 (PAI-1) is the major determinant of fibrinolytic activity. PAI-1 concentrations are elevated in obesity, type 2 diabetes and metabolic syndrome (MetS). On the other...